Decreased prefrontal cortical dopamine transmission in alcoholism

American Journal of Psychiatry

Volumn 171, Issue 8, 2014, Pages 881-888

  Narendran, Rajesh ^a   Mason, Neale Scott ^a   Paris, Jennifer ^a   Himes, Michael L ^a   Douaihy, Antoine B ^a   Frankle, W Gordon ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; FLB 457 C 11; RADIOLIGAND; UNCLASSIFIED DRUG;

ADULT; ALCOHOL CONSUMPTION; ALCOHOLISM; ARTICLE; CEREBELLUM; CONTROLLED STUDY; DISEASE DURATION; DOPAMINE RELEASE; DOPAMINERGIC TRANSMISSION; FEMALE; HUMAN; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; MESENCEPHALON; POSITRON EMISSION TOMOGRAPHY; PREFRONTAL CORTEX; PRIORITY JOURNAL; TEMPORAL CORTEX; TEMPORAL LOBE;

ADOLESCENT; ADULT; ALCOHOLISM; BRAIN; CARBON RADIOISOTOPES; CASE-CONTROL STUDIES; DEXTROAMPHETAMINE; DOPAMINE; DOPAMINE ANTAGONISTS; DOPAMINE UPTAKE INHIBITORS; FEMALE; FUNCTIONAL NEUROIMAGING; HUMANS; MALE; POSITRON-EMISSION TOMOGRAPHY; PREFRONTAL CORTEX; PYRROLIDINES; SALICYLAMIDES; SYNAPTIC TRANSMISSION; YOUNG ADULT;

EID: 84905439684     PISSN: 0002953X     EISSN: 15357228     Source Type: Journal    
DOI: 10.1176/appi.ajp.2014.13121581     Document Type: Article

References (43)

1. Brozoski TJ, Brown RM, Rosvold HE, Goldman PS: Cognitive deficit caused by regional depletion of dopamine in prefrontal cortex of rhesus monkey. Science 1979;205:929-932
2. Sawaguchi T, Goldman Rakic PS: D1 dopamine receptors in prefrontal cortex: involvement in working memory. Science 1991;251:947-950
3. Bickel WK, Jarmolowicz DP, Mueller ET, Gatchalian KM, McClure SM: Are executive function and impulsivity antipodes? a conceptual reconstruction with special reference to addiction. Psychopharmacology (Berl) 2012;221:361-387
4. Longmore BE, Knight RG: The effect of intellectual deterioration on retention deficits in amnesic alcoholics. J Abnorm Psychol 1988;97:448-454
5. Goldman MS: Cognitive impairment in chronic alcoholics: some cause for optimism. Am Psychol 1983;38:1045-1054
6. OscarBerman M, Shagrin B, Evert DL, Epstein C: Impairments of brain and behavior: the neurological effects of alcohol. Alcohol Health Res World 1997;21:65-75
7. De Montis MG, Grappi S, Gambarana C, Leggio B, Nanni G, Scheggi S, Tagliamonte A: Sardinian alcoholpreferring rats show low 5HT extraneuronal levels in the mPFC and no habituation in monoaminergic response to repeated ethanol consumption in the NAcS. Brain Res 2004;1006:18-27
8. Engleman EA, Ingraham CM, McBride WJ, Lumeng L, Murphy JM: Extracellular dopamine levels are lower in the medial prefrontal cortex of alcoholpreferring rats compared to Wistar rats. Alcohol 2006;38:5-12
9. Murphy JM, Stewart RB, Bell RL, BadiaElder NE, Carr LG, McBride WJ, Lumeng L, Li TK: Phenotypic and genotypic characterization of the Indiana University rat lines selectively bred for high and low alcohol preference. Behav Genet 2002;32:363-388
10. Bassareo V, Tanda G, Petromilli P, Giua C, Di Chiara G: Nonpsychostimulant drugs of abuse and anxiogenic drugs activate with differential selectivity dopamine transmission in the nucleus accumbens and in the medial prefrontal cortex of the rat. Psychopharmacology (Berl) 1996;124:293-299
11. Hegarty AA, Vogel WH: Modulation of the stress response by ethanol in the rat frontal cortex. Pharmacol Biochem Behav 1993;45:327-334
12. Murphy JM, McBride WJ, Gatto GJ, Lumeng L, Li TK: Effects of acute ethanol administration on monoamine and metabolite content in forebrain regions of ethanoltolerant and nontolerant alcoholpreferring (P) rats. Pharmacol Biochem Behav 1988;29:169-174
13. Hodge CW, Chappelle AM, Samson HH: Dopamine receptors in the medial prefrontal cortex influence ethanol and sucrosereinforced responding. Alcohol Clin Exp Res 1996;20:1631-1638
14. Samson HH, Chappell A: Dopaminergic involvement in medial prefrontal cortex and core of the nucleus accumbens in the regulation of ethanol self-Administration: a dualsite microinjection study in the rat. Physiol Behav 2003;79:581-590
15. Breier A, Su TP, Saunders R, Carson RE, Kolachana BS, de Bartolomeis A, Weinberger DR, Weisenfeld N, Malhotra AK, Eckelman WC, Pickar D: Schizophrenia is associated with elevated amphetamineinduced synaptic dopamine concentrations: evidence from a novel positron emission tomography method. Proc Natl Acad Sci USA 1997;94:2569-2574
16. Volkow ND, Wang GJ, Telang F, Fowler JS, Logan J, Jayne M, Ma Y, Pradhan K, Wong C: Profound decreases in dopamine release in striatum in detoxified alcoholics: possible orbitofrontal involvement. J Neurosci 2007;27:12700-12706
17. Martinez D, Gil R, Slifstein M, Hwang DR, Huang Y, Perez A, Kegeles L, Talbot P, Evans S, Krystal J, Laruelle M, AbiDargham A: Alcohol dependence is associated with blunted dopamine transmission in the ventral striatum. Biol Psychiatry 2005;58:779-786
18. Narendran R, Frankle WG, Mason NS, Rabiner EA, Gunn RN, Searle GE, Vora S, Litschge M, Kendro S, Cooper TB, Mathis CA, Laruelle M: Positron emission tomography imaging of amphetamineinduced dopamine release in the human cortex: a comparative evaluation of the high affinity dopamine D2/3 radiotracers [11C]FLB 457 and [11C]fallypride. Synapse 2009;63:447-461
19. 11C]FLB 457: reproducibility studies. Synapse 2011;65:35-40
20. Narendran R, Himes M, Mason NS: Reproducibility of postamphetamine [11C]FLB 457 binding to cortical D2/3 receptors. PLoS ONE 2013;8:e76905
21. 11C]FLB 457: implications for measuring cortical dopamine release. Synapse 2011;65:991-997
22. Narendran R, Jedema HP, Lopresti B, Mason NS, Gurnsey K, Ruskiewicz J, Chen CM, Deuitch L, Frankle G, Bradberry C: Imaging dopamine transmission in the frontal cortex: a simultaneous microdialysis and [11C]FLB 457 PET study. Mol Psychiatry 2014;19:302-310
23. Sullivan JT, Sykora K, Schneiderman J, Naranjo CA, Sellers EM: Assessment of alcohol withdrawal: the Revised Clinical Institute Withdrawal Assessment for Alcohol Scale (CIWAAr). Br J Addict 1989;84:1353-1357
24. Selzer ML: The Michigan Alcoholism Screening Test: the quest for a new diagnostic instrument. Am J Psychiatry 1971;127:1653-1658
25. Skinner HA, Allen BA: Alcohol dependence syndrome: measurement and validation. J Abnorm Psychol 1982;91:199-209
26. Halldin C, Farde L, Högberg T, Mohell N, Hall H, Suhara T, Karlsson P, Nakashima Y, Swahn CG: Carbon11FLB 457: a radioligand for extrastriatal D2 dopamine receptors. J Nucl Med 1995;36:1275-1281
27. Sudo Y, Suhara T, Inoue M, Ito H, Suzuki K, Saijo T, Halldin C, Farde L: Reproducibility of [11C]FLB 457 binding in extrastriatal regions. Nucl Med Commun 2001;22:1215-1221
28. Reimer ML, Mamer OA, Zavitsanos AP, Siddiqui AW, Dadgar D: Determination of amphetamine, methamphetamine and desmethyldeprenyl in human plasma by gas chromatography/negative ion chemical ionization mass spectrometry. Biol Mass Spectrom 1993;22:235-242
29. Smith SM, Jenkinson M, Woolrich MW, Beckmann CF, Behrens TE, JohansenBerg H, Bannister PR, De Luca M, Drobnjak I, Flitney DE, Niazy RK, Saunders J, Vickers J, Zhang Y, De Stefano N, Brady JM, Matthews PM: Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage 2004;23(suppl 1):S208-S219
30. AbiDargham A, Martinez D, Mawlawi O, Simpson N, Hwang DR, Slifstein M, Anjilvel S, Pidcock J, Guo NN, Lombardo I, Mann JJ, Van Heertum R, Foged C, Halldin C, Laruelle M: Measurement of striatal and extrastriatal dopamine D1 receptor binding potential with [11C]NNC 112 in humans: validation and reproducibility. J Cereb Blood Flow Metab 2000;20:225-243
31. AbiDargham A, Mawlawi O, Lombardo I, Gil R, Martinez D, Huang Y, Hwang DR, Keilp J, Kochan L, Van Heertum R, Gorman JM, Laruelle M: Prefrontal dopamine D1 receptors and working memory in schizophrenia. J Neurosci 2002;22:3708-3719
32. Innis RB, Cunningham VJ, Delforge J, Fujita M, Gjedde A, Gunn RN, Holden J, Houle S, Huang SC, Ichise M, Iida H, Ito H, Kimura Y, Koeppe RA, Knudsen GM, Knuuti J, Lammertsma AA, Laruelle M, Logan J, Maguire RP, Mintun MA, Morris ED, Parsey R, Price JC, Slifstein M, Sossi V, Suhara T, Votaw JR, Wong DF, Carson RE: Consensus nomenclature for in vivo imaging of reversibly binding radioligands. J Cereb Blood Flow Metab 2007;27:1533-1539
33. Cunningham VJ, Rabiner EA, Slifstein M, Laruelle M, Gunn RN: Measuring drug occupancy in the absence of a reference region: the Lassen plot revisited. J Cereb Blood Flow Metab 2010;30:46-50
34. Benjamini Y, Hochberg Y: Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc 1995;57:289-300
35. Narendran R, Mason NS, Laymon C, Lopresti B, Velasquez N, May M, Kendro S, Martinez D, Mathis C, Frankle G: A comparative evaluation of the dopamine D2/3 agonist radiotracer [11C] NPA and antagonist [11C]raclopride to measure amphetamineinduced dopamine release in the human striatum. J Pharmacol Exp Ther 2010;63:574-584
36. Koob GF, Volkow ND: Neurocircuitry of addiction. Neuropsychopharmacology 2010;35:217-238
37. Koob GF: Theoretical frameworks and mechanistic aspects of alcohol addiction: alcohol addiction as a reward deficit disorder. Curr Top Behav Neurosci 2013;13:3-30
38. Floresco SB, Magyar O: Mesocortical dopamine modulation of executive functions: beyond working memory. Psychopharmacology (Berl) 2006;188:567-585
39. Grace AA: The tonic/phasic model of dopamine system regulation and its implications for understanding alcohol and psychostimulant craving. Addiction 2000;95(suppl 2):S119-S128
40. 11C]raclopride. Biol Psychiatry 2010;68:689-696
41. He J, Crews FT: Increased MCP1 and microglia in various regions of the human alcoholic brain. Exp Neurol 2008;210:349-358
42. Gilman S, Koeppe RA, Adams KM, Junck L, Kluin KJ, JohnsonGreene D, Martorello S, Heumann M, Bandekar R: Decreased striatal monoaminergic terminals in severe chronic alcoholism demonstrated with (+) [11C]dihydrotetrabenazine and positron emission tomography. Ann Neurol 1998;44:326-333
43. Kopera M, Wojnar M, Brower K, Glass J, Nowosad I, Gmaj B, Szelenberger W: Cognitive functions in abstinent alcoholdependent patients. Alcohol 2012;46:665-671